Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Asset Utilization Ratio (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.73 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio rose 198.32% year-over-year to 0.73; the TTM value through Mar 2026 reached 0.73, up 198.32%, while the annual FY2025 figure was 0.55, 293.84% up from the prior year.
  • Asset Utilization Ratio hit 0.73 in Q1 2026 for Phathom Pharmaceuticals, up from 0.7 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.73 in Q1 2026 and bottomed at 0.16 in Q1 2023.
  • Average Asset Utilization Ratio over 5 years is 0.18, with a median of 0.05 recorded in 2024.
  • Year-over-year, Asset Utilization Ratio soared 101.41% in 2023 and then surged 6789.17% in 2024.
  • Phathom Pharmaceuticals' Asset Utilization Ratio stood at 0.15 in 2022, then skyrocketed by 101.41% to 0.0 in 2023, then soared by 6789.17% to 0.14 in 2024, then skyrocketed by 385.68% to 0.7 in 2025, then rose by 3.56% to 0.73 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.73, 0.7, and 0.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.